Phathom Pharmaceuticals Inc. – Market Activity Summary (26 Nov 2026)
- Closing Price (12:56 PM CET, 26 Nov 2026): USD 5.74
- Price Change (24 hrs): Down 18.12 %
- Current Market Capitalisation: USD 464.4 million
- Shares Outstanding: 80.9 million
- Volume (last 24 hrs): USD 27.9 million worth of shares traded
- Change Since End of Last Month: Down 18.93 %
- 200‑Day Simple Moving Average: USD 10.67
- 52‑Week High: USD 18.31 (23 Dec 2025)
- 52‑Week Low: USD 5.02 (23 Oct 2026)
24‑Hour Performance of Related Stocks
| Ticker | 24‑Hr Change | Current Price (USD) | Market Cap (USD mn) |
|---|---|---|---|
| ACRS – Aclaris Therapeutics | –2.09 % | 3.75 | 552 |
| CBIO – Crescent Biopharma | –2.44 % | 12.82 | 548.7 |
| FLGT – Fulgent Genetics | +0.55 % | 20.10 | 553.1 |
| MYGN – Myriad Genetics | +1.04 % | 5.82 | 556.7 |
| STTK – Shattuck Labs | –1.96 % | 5.49 | 551.0 |
Company Overview
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for gastrointestinal (GI) diseases and disorders. The company operates within the health‑care sector, serving the gastrointestinal and pharmaceutical industries in Illinois. Phathom is listed on the Nasdaq stock exchange and provides additional information on its corporate website at www.phathompharma.com .
